REPROS THERAPEUTICS INC. — key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2016)

$47.0K

Net Income/Loss (FY2016)

-$17.3M

Total Assets (FY2016)

$8.8M

Total Equity (FY2016)

$6.1M

Cash Flows from Operating Activities (FY2016)

-$15.6M

Source: REPROS THERAPEUTICS INC. 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.